CLIC-2201
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CLIC-2201, covering 2026-04-03 to 2026-04-03. Get the full timeline:
Most recent: Clinical Trial Update: CLIC-2201 for the Treatment of Relapsed/Refractory B Cell Malignancies [Phase 1]